References
- Graf C, Battisti WP, Bridges D, et al. Good publication practice for communicating company sponsored medical research: the GPP2 guidelines. BMJ 2009;339:b4330
- Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Ann Intern Med 2010;152:726-32
- Dickersin K, Rennie D. Registering clinical trials. JAMA 2003;290:516-23
- Viergever RF, Ghersi D. The quality of registration of clinical trials. PLoS One 2011;6(2):e14701
- Huić M, Marušić M, Marušić A. Completeness and changes in registered data and reporting bias of randomized controlled trials in ICMJE journals after trial registration policy. PLoS One 2011;6:e25258
- Silverman E. What Transparency? Amylin Hid Byetta Data. Pharmalot, June 25th, 2012. Available at: http://www.pharmalot.com/2012/06/what-transparency-amylin-hid-byetta-data [Last accessed 16 August 2012]
- Silverman E. Pfizer ‘Cherry Picked’ Celebrex Study Data. Pharmalot, June 25th 2012. Available at: http://www.pharmalot.com/2012/06/pfizer-cherry-picked-celebrex-study-data [Last accessed 16 August 2012]
- O’Reilly K. Drugmakers pledge transparency to tackle credibility problem in journals. American Medical News, April 12th 2012. Available at: http://www.ama-assn.org/amednews/m/2012/05/21/psb0521.htm [Last accessed 16 August 2012]
- Lehman R, Loder E. Missing clinical trial data. BMJ 2012;344:d8158
- Doshi P, Jefferson T, Del Mar C. The imperative to share clinical study reports: recommendations from the Tamiflu experience. PLoS Med 2012;9:e1001201
- Gøtzsche PC, Jørgensen AW. Opening up data at the European Medicines Agency. The Nordic Cochrane Centre, 2011. Available at: http://www.cochrane.dk/research/EMA/index.htm [Last accessed 16 August 2012]
- Eichler H-G, Abadie E, Breckenridge A, et al. Open clinical trial data for all? A view from regulators. PLoS Med 2012;9:e1001202
- European Medicines Agency. Transparency policy. European Medicines Agency, 2012. Available at: http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/document_listing/document_listing_000187.jsp&mid=WC0b01ac0580050108 [Last accessed 16 August 2012]
- European Medicines Agency. Workshop on access to clinical trial data and transparency. EMA/406355/2012. European Medicines Agency, 2012. Available at: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2012/07/WC500130161.pdf [Last accessed 16 August 2012]
- Eyding D, Lelgemann M, Grouven U, et al. Reboxetine for acute treatment of major depression: systematic review and meta-analysis of published and unpublished placebo and selective serotonin reuptake inhibitor controlled trials. BMJ 2010;341:c4737
- Nature Publishing Group. Shining a light on trial data. Nature Biotechnology 2012;30:371
- Mansell P. EFPIA backs move towards full clinical data transparency. Pharma Times, 2012. Available at: http://www.pharmatimes.com/Article/11-09-06/EFPIA_backs_move_towards_full_clinical_data_transparency.aspx [Last accessed 16 August 2012]